ERISA Ledger · U.S. DOL EBSA Form 5500 (2024)

Paratek Pharmaceuticals, INC.

Official 2024 U.S. DOL Form 5500 summary for Paratek Pharmaceuticals, INC. (Paratek Pharmaceuticals, INC. Profit Sharing 401(k) Plan · EIN 33-0960223 · PN 001): $47.92M net assets, 322 active participants, and $14.25 per $10,000 (14.25 bps).

Reported Form 5500 Fee & Service Summary

Plan SponsorParatek Pharmaceuticals, INC.
Filing IdentifierParatek Pharmaceuticals, INC. Profit Sharing 401(k) Plan · EIN 33-0960223 · PN 001
Plan Category & State401(k) Defined Contribution (MA)
Asset-Size Peer Cohort$25M-$100M
Plan Net Assets (2024)$47.92M
Active Participants322
Direct Admin Fee Rate$14.25 per $10,000 (14.25 bps)
Cohort Peer Median$19.23 per $10,000 (19.23 bps)
Primary Recordkeeper / ProviderFidelity Investments
Schedule H Line 4a RemittanceTimely Employer Remittance (0 reported on Line 4a)

Browse all 78,373 plans & Schedule C vendors · Methodology · Meru AI